InvestorsHub Logo
Followers 35
Posts 5366
Boards Moderated 0
Alias Born 10/05/2021

Re: exwannabe post# 429891

Monday, 12/27/2021 12:10:55 PM

Monday, December 27, 2021 12:10:55 PM

Post# of 723475
2018 JTM paper shows the trial is a success. Aplhapuppy analysis predicts the trial is a success. Both of these are based on the original endpoints. The new points increases the chances of success from the 6th endpoint. 6th is tumor infiltration comparison bet treatment and placebo. When yes, you go to 5th endpoint which is OS comparison; when you pass that you go to 4th where the PFS is compared; alphapuppy says passed on adjudicated ones; 3rd is comparing confirmed progressions; 2nd is a piece of cake comparing rGBM with ECs; and so is the primary OS Vs ECs. Where is the failure here you fud master?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News